Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2019

May 15, 2019

BUY
$34.52 - $53.29 $5.97 Million - $9.22 Million
173,000 Added 8650.0%
175,000 $7.88 Million
Q2 2018

Aug 14, 2018

SELL
$23.62 - $42.29 $1.73 Million - $3.09 Million
-73,100 Reduced 97.34%
2,000 $122,000
Q1 2018

May 15, 2018

BUY
$22.49 - $34.56 $1.69 Million - $2.6 Million
75,100 New
75,100 $1.94 Million

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.